Trial Profile
A long-term, observational cumulative registry study investigating the long-term efficacy and safety of testosterone undecanoate treatment in hypogonadal men: a real world study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2020
Price :
$35
*
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hypogonadism
- Focus Adverse reactions; Therapeutic Use
- 04 Sep 2020 Results presented at the 2020 European and International Congress on Obesity
- 08 Dec 2017 Results assessing progression from prediabetes to diabetes in hypogonadal men treated with testosterone (n=175) presented at the 2017 Congress of the International Diabetes Federation
- 15 Sep 2017 Results (n=45) related to progression from prediabetes to type 2 diabetes were presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes